HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alpha-1 anti-trypsin and CD30 expression occur in parallel in activated T cells.

Abstract
We have performed an immunohistochemical study of immunoblastic T cell lymphoma and enteropathy-associated T cell lymphoma for alpha-1 anti-trypsin and CD30. Cytoplasmic staining for alpha 1 anti-trypsin is present in the malignant cells in both types of T cell neoplasm which also express CD30, a marker of lymphoid activation. Peripheral blood T lymphocytes on stimulation with mitogen also show granular cytoplasmic expression of alpha 1 anti-trypsin. Time course studies show that this parallels the expression of CD30. Alpha 1 anti-trypsin expression appears therefore to be associated with activation in T cells. Further studies of sub-fractionated T lymphocytes in vitro suggest that the expression of alpha 1 anti-trypsin on activation is not restricted to an individual lymphocyte subset.
AuthorsM S Bashir, D B Jones, D H Wright
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 88 Issue 3 Pg. 543-7 (Jun 1992) ISSN: 0009-9104 [Print] England
PMID1318806 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD
  • Antigens, Neoplasm
  • Ki-1 Antigen
  • Ki-67 Antigen
  • Nuclear Proteins
  • alpha 1-Antitrypsin
Topics
  • Antigens, CD (biosynthesis)
  • Antigens, Neoplasm (biosynthesis)
  • Gene Expression
  • Humans
  • Immunophenotyping
  • Ki-1 Antigen
  • Ki-67 Antigen
  • Lymphocyte Activation (physiology)
  • Lymphoma, T-Cell (immunology)
  • Nuclear Proteins (biosynthesis)
  • T-Lymphocytes (metabolism)
  • alpha 1-Antitrypsin (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: